Pfizer and Glaxo are safe bets for risk averse investors: Gaurang Shah

Gaurang Shah, Asst VP, Geojit BNP Paribas Financial Services in an interview with ET Now talks about pharma stocks.

What about the pure defensives, the entire pharma lot would you be trading anything from there?

We have a couple of ideas as far as pharma is concerned midcap pharma especially a buy call on Cipla and Glenmark is from our side. Aurobindo pharma definitely there, Lupin again another one over there, Biocon and Strides Arcolab.

I think these are the midcap domestic pharma ideas that we share but I think if one has to be defensive the point I think Pfizer and Glaxo are definitely a safe bet if somebody is definitely a risk averse.